Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFß) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role.
Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock and on LinkedIn.
Summary of Position:
As the Medical Affairs Director, this person will be a strategic thought and operational partner providing expert medical leadership and contributing to the development and execution of the Country launch strategy. This person will lead the Germany country launch strategy for Rare Disease, medical affairs content development, KOL engagement planning including educational initiatives, and support our cross-functional teams in Europe, including Value & Access, Commercial, and Patient Advocacy. As a key member of the European Medical team, reporting to Head of Europe, Medical Affairs, this person will be accountable for advancing Scholar Rock’s (SRK’s) scientific and medical affairs leadership in Rare Neuromuscular Diseases including Spinal Muscular Atrophy and other pipeline indications in Germany. This person will thrive in this role if he/she is a self-starter, a highly collaborative individual, and have a “Will-Do” attitude, who is driven to make a positive impact on patients and their families in this rare disease space.